دورية أكاديمية
Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases.
العنوان: | Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases. |
---|---|
المؤلفون: | Anhê FF; Department of Biochemistry and Biomedical Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada., Jensen BAH; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Perazza LR; Quebec Heart and Lung Research Institute, Laval University, Quebec, Canada., Tchernof A; Quebec Heart and Lung Research Institute, Laval University, Quebec, Canada., Schertzer JD; Department of Biochemistry and Biomedical Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada., Marette A; Quebec Heart and Lung Research Institute, Laval University, Quebec, Canada. |
المصدر: | Journal of lipid and atherosclerosis [J Lipid Atheroscler] 2021 May; Vol. 10 (2), pp. 123-129. Date of Electronic Publication: 2021 Feb 09. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Korean Society of Lipid and Atherosclerosis Country of Publication: Korea (South) NLM ID: 101610890 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2287-2892 (Print) Linking ISSN: 22872892 NLM ISO Abbreviation: J Lipid Atheroscler Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Publication: Seoul, Korea : Korean Society of Lipid and Atherosclerosis Original Publication: Seoul : Korean Society of Lipidology and Atherosclerosis, [2012]- |
مستخلص: | Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases. Competing Interests: Conflict of Interest: The authors have no conflict of interest to declare. (Copyright © 2021 The Korean Society of Lipid and Atherosclerosis.) |
References: | Nat Med. 2017 Jan;23(1):107-113. (PMID: 27892954) mBio. 2016 Apr 05;7(2):e02210-15. (PMID: 27048804) J Clin Endocrinol Metab. 2020 Jul 1;105(7):. (PMID: 32301490) EMBO Mol Med. 2011 Sep;3(9):559-72. (PMID: 21735552) Cell. 2015 Dec 17;163(7):1585-95. (PMID: 26687352) Gut. 2020 Oct;69(10):1724-1726. (PMID: 32518079) Lab Invest. 2019 Mar;99(3):346-357. (PMID: 30068915) Toxicol Lett. 2017 Feb 5;267:32-38. (PMID: 28049038) J Am Heart Assoc. 2017 Sep 4;6(9):. (PMID: 28871042) Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1448-56. (PMID: 27230129) Cell. 2016 Mar 24;165(1):111-124. (PMID: 26972052) Nutrients. 2019 Aug 18;11(8):. (PMID: 31426593) Nat Commun. 2016 Nov 14;7:13329. (PMID: 27841267) Nat Med. 2019 Jul;25(7):1031-1033. (PMID: 31263287) J Nutr Sci Vitaminol (Tokyo). 2013;59(2):144-7. (PMID: 23727645) Basic Res Cardiol. 2020 Jun 25;115(4):47. (PMID: 32588196) Nat Med. 2019 Jul;25(7):1096-1103. (PMID: 31263284) Arterioscler Thromb Vasc Biol. 2011 May;31(5):1093-9. (PMID: 21330608) J Am Med Dir Assoc. 2015 Nov 1;16(11):933-9. (PMID: 26363864) Am J Physiol Endocrinol Metab. 2020 Aug 1;319(2):E305-E314. (PMID: 32516028) Cell Res. 2020 Jun;30(6):492-506. (PMID: 32433595) Diabetes. 2011 Sep;60(9):2206-15. (PMID: 21715553) J Am Coll Cardiol. 2020 Feb 25;75(7):763-772. (PMID: 32081286) Blood. 2016 May 19;127(20):2460-71. (PMID: 26989200) J Nutr Biochem. 2020 Apr;78:108341. (PMID: 32004931) Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19440-5. (PMID: 18032608) J Am Heart Assoc. 2020 May 18;9(10):e016223. (PMID: 32390485) Diabetes. 2007 Jul;56(7):1761-72. (PMID: 17456850) EMBO Mol Med. 2015 Feb 09;7(3):259-74. (PMID: 25666722) J Am Coll Cardiol. 2015 Oct 13;66(15):1643-53. (PMID: 26449133) Nat Med. 2010 Feb;16(2):228-31. (PMID: 20081863) Cell Metab. 2017 May 2;25(5):1063-1074.e3. (PMID: 28434881) Circulation. 2016 Jun 14;133(24):2434-46. (PMID: 27143680) J Am Heart Assoc. 2016 Feb 22;5(2):. (PMID: 26903003) Nature. 2011 Apr 7;472(7341):57-63. (PMID: 21475195) Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. (PMID: 23671105) Am J Physiol Endocrinol Metab. 2020 Apr 1;318(4):E579-E585. (PMID: 32101030) Nat Med. 2013 May;19(5):576-85. (PMID: 23563705) Nat Rev Endocrinol. 2015 Oct;11(10):577-91. (PMID: 26260141) N Engl J Med. 2013 Apr 25;368(17):1575-84. (PMID: 23614584) Eur J Nutr. 2021 Mar;60(2):747-758. (PMID: 32440731) Gut. 2004 Nov;53(11):1558-60. (PMID: 15479670) |
فهرسة مساهمة: | Keywords: Akkermansia; Diabetes mellitus, type 2; Lipopolysaccharides; Obesity; Peptidoglycan |
تواريخ الأحداث: | Date Created: 20210607 Latest Revision: 20210608 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC8159759 |
DOI: | 10.12997/jla.2021.10.2.123 |
PMID: | 34095007 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!